| Name | Title | Contact Details |
|---|
Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.
Allied Healthcare International Inc. is a provider of flexible, or temporary, healthcare staffing to the healthcare industry in the United Kingdom. The Company provides personal or basic care and nursing services in the home, in nursing and care homes
St. Mary`s Healthcare offers a continuum of services designed to fulfill the total healthcare needs of the community, while being the lowest cost provider. In addition to our 143 bed hospital, a 160 bed nursing home and a 10 bed acute rehabilitation unit, St. Mary`s provides highly accessible healthcare through its seven offsite primary care centers and behavioral health service locations throughout two counties. We treat more than 290,000 outpatient visits a year. Founded by the Sisters of St. Joseph of Carondelet in 1903, and as a member of Ascension since 2002, St. Mary`s is dedicated to improving the health of the community with special attention to the poor and underserved. By addressing the spiritual, social, emotional and physical needs of our patients, we strive to provide an exceptional patient experience and a model community for our associates and medical staff.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Dinatec is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.